Paper
0
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease
Authors
Geert D’Haens,Séverine Vermeire
Guy Lambrecht,Filip Baert,Peter Bossuyt,Benjamin Pariente,Anthony Buisson,Yoram Bouhnik,Jérôme Filippi,Janneke Woude,Philippe Hootegem,Jacques Moreau,Édouard Louis,Denis Franchimont,Martine Vos,Fazia Mana,Laurent Peyrin‐Biroulet,Hédia Brixi,Matthieu Allez,Philip Caenepeel,Alexandre Aubourg,Bas Oldenburg,Marieke Pierik,Ann Gils,Sylvie Chevret,David Laharie,Patricia Détré,Marie-Jo Bertin,Sabrina Williams
+27 authors
,Laurent Peyrin–BirouletJournal
Published
Jan 6, 2018
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This PDF hasn't been uploaded yet.
Do not upload any copyrighted content to the site, only open-access content.
or